nfection
Conditions
Interventions
test group:Pharmacist intervention
Control group:No pharmacist intervention
Sponsors
The First Affiliated Hospital of Bengbu Medical College
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) The experimental group was a clinical pharmacist who had been monitored by vancomycin blood concentration and given individualized medication guidance; (2) The data collected by the experimental group was the valley concentration of vancomycin plasma concentration, but not the peak. Concentration or concentration monitored immediately after administration; (3) complete clinical data; (4) gender, admission to the department is not limited; (5) the patient's disease type is not limited.
Exclusion criteria
Exclusion criteria: (1) Vancomycin was not used to treat infection during clinical treatment; (2) patients had missing basic information and clinical data were incomplete; (3) vancomycin blood concentration was monitored as peak concentration; (4) vancomycin Patients who are administered locally.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cystatin C; | — |
Countries
China
Contacts
Public ContactQingping Shi
The First Affiliated Hospital of Bengbu Medical College
Outcome results
None listed